Collegium Reports First Quarter 2023 Financial Results : vim

– Generated Record Net Revenue of $144.8 Million – – Delivered Record Belbuca® and Xtampza® ER Net Revenue – – Ended Q1’23 with Cash Balance of $269.5... | May 4, 2023

Related Keywords

Massachusetts , United States , American , Marissa Samuels , Christopher James , Joe Ciaffoni , Colleen Tupper , Us Drug Enforcement Agency , Collegium Pharmaceutical Inc , Pamerican Academy Of Pain Medicine , Corporate Communications , While The Company , Nasdaq , Generated Record Net Revenue , Delivered Record , Cash Balance , Reaffirmed Full Year , Conference Call Scheduled , Chief Executive Officer , Chief Financial Officer , American Academy , Pain Medicine , Annual Meeting , Product Revenues , Adjusted Operating Expenses , Excluding Stock Based Compensation , Quarter Ended March , Call Information , Collegium Pharmaceutical , Net Income , Adjusted Earnings Per , Regulations K , Private Securities Litigation Reform Act , Enforcement Agency , Annual Reports , Quarterly Reports , Condensed Statements , Months Ended March , Adjusted Operating , Adjusted Net Income , Convertible Notes , Nc Stock Exchange , News , Information , Press Release , Enerated , Record , Pet , Revenue , F , Billion , Elivered , End , Dr , Nded , Ith , Cash , Balance , F Coll Us19459j1043 ,